Francesco Galimi
Chief Tech/Sci/R&D Officer presso ADICET BIO, INC.
Patrimonio netto: 239 232 $ in data 31/03/2024
Profilo
Francesco Galimi is currently the Chief Medical Officer & Senior Vice President at Adicet Therapeutics, Inc. and Adicet Bio, Inc. He previously worked as the General Manager-Global Program at Amgen, Inc. from 2015 to 2019 and as the Head-Clinical Development at Onyx Pharmaceuticals, Inc. from 2014 to 2015.
He also served as the Chief Medical Officer & Senior Vice President at resTORbio, Inc. Dr. Galimi earned a doctorate degree from the University of Turin.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ADICET BIO INC
0.12% | 24/01/2024 | 101 801 ( 0.12% ) | 239 232 $ | 31/03/2024 |
Posizioni attive di Francesco Galimi
| Società | Posizione | Inizio |
|---|---|---|
| ADICET BIO, INC. | Chief Tech/Sci/R&D Officer | 01/09/2019 |
Adicet Therapeutics, Inc.
 Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Chief Tech/Sci/R&D Officer | 01/09/2019 |
Precedenti posizioni note di Francesco Galimi
| Società | Posizione | Fine |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | 01/01/2019 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 01/01/2015 |
| ADICET BIO, INC. | Chief Tech/Sci/R&D Officer | - |
Formazione di Francesco Galimi
| University of Turin | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| ADICET BIO, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Adicet Therapeutics, Inc.
Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Health Technology |
resTORbio, Inc.
 resTORbio, Inc. BiotechnologyHealth Technology resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Francesco Galimi
